BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 6, 2003
View Archived Issues
Novel antidiabetic beta3-adrenoceptor agonists covered by Wyeth patent
Read More
New inhibitors of SGLT transporters discovered by Kyowa Hakko scientists
Read More
Antiallergic peptides presented by Hayashibara and Sankyo researchers
Read More
Boehringer Ingelheim prepares and tests series of HCV NS5B inhibitors
Read More
NeoTherapeutics describes new agents for neuronal stimulation and regeneration
Read More
Novel mGluR antagonists with utility in cerebral infarction and neuropathic pain
Read More
Antibacterial quinolizinones in early development at Sato
Read More
Mercian claims HMG-CoA-inhibitory mevastatin analogues
Read More
New ascorbate-tocopherol adduct with dual activity as elastase inhibitor and free radical scavenger
Read More
Novuspharma updates R&D development and clinical progress
Read More
Reduced hyperinflammatory response reported after postinjury PolyHeme rescue
Read More
IL-2 combined with HAART reported to enhance immune restoration in HIV infection
Read More
Versicor and Biosearch Italia complete merger, summarize results for 2002
Read More
Avelox approved for CAP pneumonia due to penicillin-resistant S. pneumoniae
Read More
CG-53135 cleared to enter phase I trials
Read More
Recombinant AAT therapy enters phase I
Read More
Priority review granted for Arixtra sNDA
Read More
Myoview approved for assessment of left ventricular function
Read More
Consistent positive weight loss trends observed in AOD-9604 trial
Read More
Phase III protocol for tesmilifene accepted by FDA
Read More
New phase II study assesses NS-2330 for advanced Parkinson's disease
Read More
Ilex Campath rights broadened to all nononcology therapeutic uses
Read More
Synergistic antitumor activity for antiestrogen/FTI combinations in ER-positive breast cancer
Read More
Kyorin and Eisai to jointly market rizatriptan for migraine in Japan
Read More
BioSante completes menopause phase II/III trial of Bio-E-Gel
Read More
Calanolide A combination therapy for HIV completes clinical trial
Read More
